Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia.

Heart Fail Clin

Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", Via L. Bianchi, 80131 Naples, Italy; Institute of Cardiovascular Sciences, University College of London and St. Bartholomew's Hospital, Grower Street, London WC1E 6DD, UK. Electronic address:

Published: January 2022

Friedreich ataxia (FRDA) is an autosomal recessive neurodegenerative disorder caused by a homozygous GAA triplet repeat expansion in the frataxin gene. Cardiac involvement, usually manifesting as hypertrophic cardiomyopathy, can range from asymptomatic cases to severe cardiomyopathy with progressive deterioration of the left ventricular ejection fraction and chronic heart failure. The management of cardiac involvement is directed to prevent disease progression and cardiovascular complications. However, direct-disease therapies are not currently available for FRDA. The present review aims to describe the current state of knowledge regarding cardiovascular involvement of FRDA, focusing on clinical-instrumental features and management of cardiac manifestation.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hfc.2021.07.001DOI Listing

Publication Analysis

Top Keywords

cardiovascular involvement
8
friedreich ataxia
8
cardiac involvement
8
management cardiac
8
diagnosis management
4
management cardiovascular
4
involvement
4
involvement friedreich
4
ataxia friedreich
4
ataxia frda
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!